MetLife Investment Management’s MasterBrand MBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
119,275
+44,156
+59% +$377K 0.01% 1415
2026
Q1
$624K Sell
75,119
-1,400
-2% -$15.1K ﹤0.01% 1643
2025
Q4
$845K Hold
76,519
﹤0.01% 1521
2025
Q3
$1.01M Hold
76,519
﹤0.01% 1443
2025
Q2
$836K Hold
76,519
﹤0.01% 1400
2025
Q1
$999K Sell
76,519
-1,177
-2% -$17.9K 0.01% 1364
2024
Q4
$1.14M Buy
77,696
+4,229
+6% +$72.1K 0.01% 1346
2024
Q3
$1.36M Hold
73,467
0.01% 1215
2024
Q2
$1.08M Buy
73,467
+6,924
+10% +$115K 0.01% 1305
2024
Q1
$1.25M Sell
66,543
-2,376
-3% -$37.7K 0.01% 1177
2023
Q4
$1.02M Hold
68,919
0.01% 1279
2023
Q3
$837K Hold
68,919
0.01% 1337
2023
Q2
$802K Buy
68,919
+64,515
+1,465% +$619K 0.01% 1395
2023
Q1
$35.4K Sell
4,404
-35
-0.8% -$309 ﹤0.01% 2740
2022
Q4
$33.5K Buy
+4,439
New +$36.4K ﹤0.01% 2792

Other funds holding MBC

MetLife Investment Management's MBC Position: Q2 2026 in Review

MetLife Investment Management increased its MasterBrand (MBC) stake by 59% in Q2 2026, buying an estimated $377K and bringing the position to 119,275 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #1415.

MetLife Investment Management first reported a position in MBC in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.36M in Q3 2024. 345 funds tracked by Wall St. Rank hold MBC as of Q2 2026.

  • MetLife Investment Management held 119,275 shares of MasterBrand worth $1.23M as of Q2 2026.
  • MetLife Investment Management bought 44,156 MasterBrand shares in Q2 2026, an estimated $377K.
  • MasterBrand made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1415 holding.
  • MetLife Investment Management first reported a position in MasterBrand in Q4 2022 and has held it in 15 quarters since.
  • MetLife Investment Management's MasterBrand position peaked at $1.36M in Q3 2024.
  • 345 funds tracked by Wall St. Rank held MasterBrand as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.